Buscar

14 resultados para "Novo Nordisk"

Ordenar por:

Relevancia Fecha Impacto

Novo Nordisk CEO explains why new GLP-1 pill expands access to the weight loss drugs

2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market

Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill

4dCNBCSaludImpacto

The AI Power List

6 eneBusiness InsiderTecnologia

Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs

5 eneDecryptSaludImpacto

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market

1 eneCNBCeconomics

Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient

30 dicCNBCCiencia

S&P 500 Hits Record Ahead of Christmas Holidays | The Close 12/24/2025

24 dicBloombergeconomicsImpacto

Shares in Wegovy-maker Novo Nordisk pop 7% after GLP-1 pill approval

23 dicCNBCSalud

A cheaper, easier-to-use version of Wegovy is coming to the US soon

23 dicBusiness InsiderSaludImpacto

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

23 dicCNBCSaludImpacto

Novo Nordisk weight-loss drug wins US approval as a daily pill

23 dicFinancial TimesSalud

FDA Approves Pill Version of Wegovy

22 dicWiredSalud